|
Direct medical costs of asthma management in a Nigerian tertiary institution
|
|
| Author:
|
KOSISOCHI AMORHA, BARTHOLOMEW NNANYERE ADOBEZE, MATHEW JEGBEFUME OKONTA
|
| Abstract:
|
To determine the direct medical cost of asthma management in a tertiary health Institution in Nigeria. This was a
retrospective, observational study conducted using the medical records of asthma patients of the University of Nigeria
Teaching Hospital (UNTH), Ituku-Ozalla, Enugu State within 1st January, 2011 to 31st December, 2016. Data were
extracted from the patients’ folders using a pro-forma document and analyzed using the IBM Statistical Product for
Services Solution (SPSS) for Windows, Version 21.0. The direct medical cost of asthma management in UNTH from
2011 to 2016 was ?2,635,078.77 representing ?7,180.05 per asthma prescription encountered. The controller
inhalers, Seretide® diskus® (50/100 and 50/250), accounted for the highest total costs with ?630,000.00 and
?318,920.00 respectively. Amoxicillin/Clavulanic acid (625mg) was the most prescribed antibiotic and spirometry
was the highest of the investigational tests. Drugs were responsible for 82.49% of the total direct cost of asthma
management. The lowest direct medical costs attributable to asthma were recorded in year 2014 while the highest
was recorded in 2016. The exchange rate was $1 to ?356, as of the time of the study. The direct medical cost of
asthma management for the study period was about ?2.6 million representing ?7,180.05 per asthma prescription
encountered. The controller inhalers containing salmeterol/fluticasone (50/100 and 50/250), accounted for the highest
total costs. Drugs accounted for more than three-quarter of the total direct costs.
|
| Keyword:
|
asthma, direct medical cost, Nigeria
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2018.10.03.069
|
| Download:
|
Request For Article
|
|
|